147 related articles for article (PubMed ID: 20814077)
1. Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects.
Rougeot C; Robert F; Menz L; Bisson JF; Messaoudi M
J Physiol Pharmacol; 2010 Aug; 61(4):483-90. PubMed ID: 20814077
[TBL] [Abstract][Full Text] [Related]
2. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways.
Javelot H; Messaoudi M; Garnier S; Rougeot C
J Physiol Pharmacol; 2010 Jun; 61(3):355-62. PubMed ID: 20610867
[TBL] [Abstract][Full Text] [Related]
3. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.
Wisner A; Dufour E; Messaoudi M; Nejdi A; Marcel A; Ungeheuer MN; Rougeot C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17979-84. PubMed ID: 17101991
[TBL] [Abstract][Full Text] [Related]
4. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice.
Popik P; Kamysz E; Kreczko J; Wróbel M
Behav Brain Res; 2010 Nov; 213(1):88-93. PubMed ID: 20438769
[TBL] [Abstract][Full Text] [Related]
5. Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice.
Tian XZ; Chen J; Xiong W; He T; Chen Q
Peptides; 2009 Jul; 30(7):1348-54. PubMed ID: 19442408
[TBL] [Abstract][Full Text] [Related]
6. STR-324, a Stable Analog of Opiorphin, Causes Analgesia in Postoperative Pain by Activating Endogenous Opioid Receptor-dependent Pathways.
Sitbon P; Van Elstraete A; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
Anesthesiology; 2016 Nov; 125(5):1017-1029. PubMed ID: 27571257
[TBL] [Abstract][Full Text] [Related]
7. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
9. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
Bardin L; Colpaert FC
Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976
[TBL] [Abstract][Full Text] [Related]
10. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
11. The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain.
Van Elstraete A; Sitbon P; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
Anesth Analg; 2018 Jun; 126(6):2102-2111. PubMed ID: 28806211
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
13. A preclinical comparison between different opioids: antinociceptive versus adverse effects.
Meert TF; Vermeirsch HA
Pharmacol Biochem Behav; 2005 Feb; 80(2):309-26. PubMed ID: 15680184
[TBL] [Abstract][Full Text] [Related]
14. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
15. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
17. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
20. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
Gairin JE; Gout R; Meunier JC; Cros J
J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
